Keywords
forced swim test
lipid profile
glucose
tryptophan
antidepressant
How to Cite
Abstract
Nicotine, in the form of tobacco smoking, is the most commonly abused drug throughout the world. It contributes to the harmful tobacco smoking habit leading to high morbidity and mortality throughout the world. The drug has addictive properties and causes drug dependence. Apart from these effects, nicotine alters a number of metabolic pathways such as lipid profile and glucose homeostasis leading to increased risk of cardiovascular diseases. Present study investigated the metabolic and behavioral effects of nicotine in stressed mice. For this purpose adult male mice were subjected to chronic nicotine treatment(3.08 mg/100 ml in drinking water) for 3 weeks followed by forced swim test (FST) and serum glucose, lipid profile and tryptophan were investigated. When swim stressed mice were compared with chow control, it was found that serum glucose (P<0.001), total cholesterol (P<0.001), triglycerides (P<0.01), and LDL cholesterol (P<0.01) were increased. Similarly glucose concentration (P<0.05), total cholesterol (P<0.05), triglycerides (P<0.01) and LDL cholesterol (P<0.05) were increased in drug treated swim stressed mice. However HDL remained unaltered in both groups. Serum tryptophan was decreased (P<0.01) in swim stressed and nicotine treated swim stressed mice. During FST, swimming behavior was significantly increased at the cost of climbing with no change in immobility in nicotine treated mice as compared to controls. It is concluded that nicotine worsens lipid profile and glucose homeostasis in stressful situations thereby increasing the risk of cardiovascular diseases in chronic smokers and the drug induced behavioral alterations may be related to the serotonergic pathway.
References
Breslau N. 1995. Psychiatric comorbodity of smoking and nicotine dependence, Behav. Genet 25(2) 95-101.
Ong AD;Walsh DA 2001 Nicotine dependence depression and moderating the role of goal cognitions Psychology of addictive Behavior Vol 15(3) 252-254.
Niaura R and Stoney CM, Herbert PN.1992 Lipids in psychological research: the last decade. Biol Psychol, 34:1- 43.
Nayanatara AK Nagaraja HS, Ramaswamy C，Bhagyalakshmi K et al. 2009 Effect of chronic unpredictable stressors on some selected lipid parameters and biochemical parameters in Wistar rats. Journal of Chinese clinical medicine, 4(2): 92-97.
Morissette SB, Tull MT, Gulliver SB, Kamholz BW, and Zimering RT. 2007 Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull, 133: 245-272.
Boos CJ and Croft AM. 2004 Smoking rates in the staff of a military field hospital before and after wartime deployment. J R Soc Med 97: 20-22
Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P.1998. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiatry, 55(2):161-6.
Quattrocki E, Baird A, Yurgelun-Todd D 2000. Biological aspects of the link between smoking and depression. Harv Rev Psychiatry. 8(3):99-110.
Seth P, Cheeta S, Tucci S, File SE.2002 Nicotinic-- serotonergic interactions in brain and behaviour. Pharmacol Biochem Behav.; 71(4):795-805.
McGill HC Jr.1979. Potential mechanisms for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med;8:390-403.
Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. 1993. Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. BBRC 23:630-40.
Chattopadhyay K., Chattopadhyay B.D. 2008 Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein Indian J Med Res, 127: 571-576
Mitchell B. 1999. Tobacco use and cessation: The adverse health effects of tobacco and tobacco related products. Primary care: Clin.Office Pract.26: 463-498
Schuitemaker GE, Dinant GJ, van der Pol GA, van Wersch JW. 2002 Relationship between smoking habits and lowdensity lipoprotein-cholesterol, high-density lipoproteincholesterol, and triglycerides in a hypercholesterolemic adult cohort, in relation to gender and age. Clin Exp Med. 2(2):83- 8.
Gossett LK, Johnson HM, Piper ME, Fiore MC, Baker TB, Stein JH. 2009 Smoking intensity and lipoprotein abnormalities in active smokers. J Clin Lipidol. 3(6):372-8.
Porsolt RD, Le Pichon M and Alfred M. 1977. Depression: A new animal model sensitive to antidepressant treatments. Nature, 266: 730-732.
Lucki I, Dalvi A and Mayorga AJ 2001. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl.), 155: 315-322.
Detke MJ, Rickets M and Lucky I. 1995. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 121: 66-72.
Hultman E. 1959. Estimation of glucose by O-toludine method. Nature, 183: 108
Bloxam, D. L. and Warren, W. H. 1974 Error in the determination of tryptophan by the method of Denckla and Dewey. A revised procedure. Analytical Biochemistry 60, 621-625.
Hayase T 2007 Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs BMC Neurosci.;8:76.
Tizabi Y, Hauser S.R, Tyler K.Y, Getachew B, Madani R, Sharma Y,and Manaye K.F. 2010. Effects of nicotine on depressive-like behavior and hippocampal volume of female wky rats. Prog Neuropsychopharmaco.l Biol. Psychiatry. 34(1): 62.
Tizabi Y, Overstreet DH, Rezvani AH, Louis VA, Clark E, Janowsky DS, Kling MA. 1999. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology.;142:193–199.
Djurić VJ, Dunn E, Overstreet DH, Dragomir A, Steiner M. 1999. Antidepressant effect of ingested nicotine in female rats of Flinders resistant and sensitive lines. Physiol Behav. 67(4):533-7.
Vázquez-Palacios G, Bonilla-Jaime H, Velázquez- Moctezuma J. 2004. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine. Pharmacol Biochem Behav.;78(1):165-9.
Slawecki CJ, Thorsell AK, El Khoury A, Mathé AA, Ehlers CL. 2005. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides; 39(4):369-77.
Picciotto MR, Addy NA, Mineur YS, Brunzell DH. 2008 It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood. Prog Neurobiol.;84(4):329-42
Vyas B.A., Vyas R.B., Joshi S.V., Khandelwal D.S.,Pachauri D.R., Kasture S.B. 2011 Antidepressive Effect of Nicotine - Role of Serotonergic System. International Journal of Pharmaceutical Research; 3(1): 61-63.
Baldessarini R.J. The Pharmacological Basis of Terapeutics. 1996. 9th Ed. (J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, Eds.) McGraw-Hill, New York.
Fuller R.W. and Roush B.W. 1973. Binding of tryptophan to plasma proteins in several species. Comparative Biochemistry and Physiology Part B: Comparative Biochemistry 46(2),15:273-276.
Pardridge, W. M.1983. Brain metabolism: A perspective from the blood-brain barrier. Physiological Reviews 63, 1481- 1535.
Leathwood P.D. 1987 Tryptophan availability and serotonin synthesis Proceedings ofthe Nutrition Society 46, 143-156
Bano S. and Dawood S. 2008. Serotonergic mediation effects of St John’s Wort in rats subjected to swim stress. Pak. J. Pharm. Sci., 21(1):63-69.
Badawy a. A. B., Evans M.& Punjani N.F. 1981. Reversal by naloxone of the effects of chronic administration of drugs of dependence on rat liver and brain tryptophan metabolism Br. J. Pharmac. 74,489-494.
Takada A, Urano T, Yoshida M, Takada Y. 1996 Comparison of changes in serotonergic measures in whole blood or plasma and brain in rats given nicotine and/or stresses. Pol J Pharmacol. ;48(2):173-7.
Suemaru K, Yasuda K, Cui R, Li B, Umeda K, Amano M, Mitsuhashi H, Takeuchi N, Inoue T, Gomita Y, Araki H. 2006 Antidepressant-like action of nicotine in forced swimming test and brain serotonin in mice. Physiol Behav. ;88(4-5):545-9.
Radahmadi M , Farrokh Shadan , Seied Morteza Karimian , Seied Shahab-e-din Sadr and Ali Nasimi. 2006. Effects of stress on exacerbation of diabetes mellitus, serum glucose and cortisol levels and body weight in rats.Pathophysiology,13:51–55
Dutour A, Boiteau V, Dadoum F, Feissel A, Atlan C and Oliver C 1996. Hormonal response to stress in brittle diabetes. Psychoneuroendocrinology, 21(6): 525–543.
Nirupama, R., Devaki, M. and Yajurvedi, H. N. 2010 Repeated acute stress induced alterations in carbohydrate metabolism in rat. Journal of stress physiology & biochemistry, 6(3):44-55.
Gutiérrez Moreno F, Rubio Montañés ML, Buñuel Alvarez JC, Guillén Galve M. 1991 An analysis of the effect of tobacco on glucose metabolism. Med Clin (Barc). 97(14):531-2.
Abd el Mohsen MM, Fahim AT, Motawi TM and Ismail NA. 1997. Nicotine and stress: effect on sex hormones and lipid profile in female rats. Pharmacol Res. 35(3):181-7.
Kumar R, Sharma MK, Puri JN, Jain IP, Singh S, Kapoor KN, Ansari NA and Singh SP. 2008. Effect of guggulipid on stress induced alteration on lipid profile in rat. J. Res. Educ. Indian Med., 9-13
Brennan FxJr, Cobb CL, Silbert L H, Watkins L R and Maier S F 1996. Peripheral Beta adrenergic receptors and stress induced hypercholestrolemia in rats. Physiol. Behav.60:1307- 1310.
Bagby GJ, Pekala PH. 1987. Lipoprotein lipase in trauma and sepsis. In Borensztajn J (ed), Lipoprotein Lipase. Chicago, Evener Publishers: 247-275
Latha MS, Vijayammal PL and Kurup PA 1993. Effect of nicotine administration on lipid metabolism in rats. Indian J Med Res.,98:44-9.
Neki NS.2002. Lipid profile in chronic smokers- A clinical study JIACM 3(1): 51-4.
Ashakumary L. and Vijayammal PL. 1997. Effect of nicotine on lipoprotein metabolism in rats. Lipids 32(3):311-315
Latha MS, Vijayammal PL and Kurup PA 1988. Effect of exposure of rats to cigarette smoke on the metabolism of lipids. Atherosclerosis. 70(3):225-31.
Laudon Meyer E, Waldenlind E, Marcus C. 2005. Lipolysis in smokers during tobacco withdrawal: a pilot study. Scand J Clin Lab Invest., 65(8):649-57.
Benowitz NL and Gourlay SG 1997. Cardiovascular toxicity of nicotine: for nicotine replacement therapy. J Am Coll Cardiol.29(7):1422-31.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.